Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Science 7 November 1975:
Vol. 190. no. 4214, pp. 576 - 578
DOI: 10.1126/science.1188356
Prev | Table of Contents | Next

Articles

Science, Vol 190, Issue 4214, 576-578
Copyright © 1975 by American Association for the Advancement of Science

articles

Synthesis of (6-3H)-1alpha-hydroxyvitamin D3 and its metabolism in vivo to (3H)-1alpha,25-dihydroxyvitamin D3

MF Holick, SA Holick, T Tavela, B Gallagher, HK Schnoes, and HF DeLuca

[6-3H]-1alpha-Hydroxyvitamin D3 was chemically synthesized and its full biological activity and radiochemical purity were demonstrated. With the use of this preparation it has been possible to demonstrate in vivo that in rats the [6-3H]-1Alpha-hydroxyvitamin D3 is converted to [6-3H]-1alpha,25-dihydroxyvitamin D3, the natural hormone. In fact, in the intestine and bone of rats given 32 picomoles of [6-3H]-1alpha-hydroxyvitamin D3 each day for 6 days, more than 80 percent of the lipid-soluble radioactivity exists as [6-3H]-1alpha,25-dihydroxyvitamin D3, a finding that suggests that much of the biological effectiveness of 1alpha-hydroxyvitamin D3 is due to its conversion to 1alpha,25-dihydroxyvitamin D3.


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Experimental diabetes reduces circulating 1,25-dihydroxyvitamin D in the rat.
L. Schneider, H. Schedl, T McCain, and M. Haussler (1977)
Science 196, 1452-1454
   Abstract »    PDF »
Renal Osteodystrophy in Children: Progress in Its Management.
J. C. M. Chan (1976)
Clinical Pediatrics 15, 996-1002
   PDF »


To Advertise     Find Products

Science. ISSN 0036-8075 (print), 1095-9203 (online)